This stock is not a joke...! What are you doing outside?

$Ocugen (OCGN.US)$ If covaxin has not been efficient enough, believe me that on the day of the meeting it was rejected. The fact that more information was requested is a good point. And one part of everything must be taken into consideration that this vaccine is composed of live attenuated virus. It is known that people deny mRNA vaccines because they are made genetically. With this I say that in view of this vaccine being like the ones we all know * attenuated virus * will generate more confidence and the FDA will have no choice but to approve it. PS: there are many prostests and the denial of genetically made vaccines, this type of vaccine is urgent.